LC-UV and LC-MS evaluation of stress degradation behavior of desvenlafaxine

Journal of Pharmaceutical Analysis

Volumn 2, Issue 4, 2012, Pages 264-271

  Pawar, Shubhangi M ^a   Khatal, Laxman D ^b   Gabhe, Satish Y ^a   Dhaneshwar, Sunil R ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b Bio analytical Technologies (India) Pvt Ltd   (India)

Author keywords

Degradation; Desvenlafaxine; Liquid chromatography mass spectrometer (LC MS); Reversed phase liquid chromatography; Stress studies; Validation

Indexed keywords

ACID; AMMONIUM ACETATE; BASE; D VENIZ; DESVENLAFAXINE; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; DRUG DOSAGE FORM; DRUG SCREENING; MASS SPECTROMETRY; OXIDATION; PHOTOLYSIS; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; STRESS;

EID: 84925835404     PISSN: 20951779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpha.2012.02.009     Document Type: Article

References (15)

1. M.R. Liebowitz, and K.A. Tourian Efficacy, safety, and tolerability of desvenlafaxine 50 mg/d for the treatment of major depressive disorder: a systematic review of clinical trials Prim. Care Companion J. Clin. Psychiatry 12 3 2010 e1 e10
2. A.I. Nichols, L.S. Richards, and J.A. Behrle The pharmacokinetics and safety of desvenlafaxine in subjects with chronic renal impairment Int. J. Clin. Pharmacol. Ther. 49 1 2011 3 13
3. A.I. Nichols, K. Focht, and Q. Jiang Pharmacokinetics of venlafaxine extended release 75 mg and desvenlafaxine 50 mg in healthy cyp2d6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study Clin. Drug Invest. 31 3 2011 155 167
4. R. Sundaraganapathy, M. Jambulingam, and S. Ananda Thangadurai Development and validation of UV spectrophotomeric method for the determination of venlafaxine hydrochloride in bulk and solid dosage forms Int. J. Pharm. Ind. Res. 1 1 2011 28 31
5. V. Somasekhar, D. Gowrisankar, and H.N. Shivakumar Development and validation of a rapid RP-HPLC method for the determination of venlafaxine hydrochloride in pharmaceutical dosage forms using experimental design Eur. J. Chem. 6 4 2009 1091 1102
6. S.L. Baldania, K.K. Bhatt, and R.S. Mehta RP-HPLC estimation of venlafaxine hydrochloride in tablet dosage forms Indian J. Pharm. Sci. 70 1 2008 124 128
7. W.J. Carneiro, C.H. Andrade, and R.C. Braga Identification of desvenlafaxine, the major active metabolite of venlafaxine, in extended-release capsules Revista Eletrônica de Farmácia 7 1 2010 39 53
8. B.A. Ebenezer, J.F. Patrick, and A.T. Mobin Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine J. Pharm. Biomed. Anal. 43 2007 1854 1859
9. S.N. Makhija, and P.R. Vavia Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations J. Pharm. Biomed. Anal. 28 6 2002 1055 1059 (Pubitemid 34607394)
10. M. Kingback, M. Josefsson, and L. Karlsson Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction J. Pharm. Biomed. Anal. 53 2010 583 590
11. W. Liu, H.L. Cai, and H.D. Li High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 850 1-2 2007 405 411 (Pubitemid 46618188)
12. P. Da Fonseca, and P.S. Bonato Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study Anal. Bioanal. Chem. 396 2 2010 817 824
13. V.D. Shirvi, K.P. Channabasavaraj, and G. Vijaya Kumar HPTLC analysis of venlafaxine hydrochloride in the bulk drug and tablets J. Planar Chromatogr. 23 5 2010 369 372
14. ICH. Topic Q1A (R2): stability testing of new drugs substances and products, in: Proceedings of the International Conference on Harmonization (ICH), IFPMA, Geneva, Switzerland, 2003.
15. ICH. Topic Q2 (R1): validation of analytical procedures: text and methodology international conference on harmonization, Geneva, Switzerland, 2005.